Malaria remains the most prevalent vector-borne infectious disease and
has the highest rates of fatality. Current antimalarial drug strategies
cure malaria or prevent infections but lack a sustained public health
impact because they fail to expedite the acquisition of protective
immunity.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/natural-immunization-against-malaria-causal-prophylaxis-antibiotics
[2] http://admin.indiaenvironmentportal.org.in/category/author/johannes-friesen
[3] http://admin.indiaenvironmentportal.org.in/category/author/olivier-silvie
[4] http://admin.indiaenvironmentportal.org.in/category/author/elyzana-dewi-putrianti-et-al
[5] http://admin.indiaenvironmentportal.org.in/category/journal/science-translational-medicine
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vector-borne-diseases
